Previous Article | Next Article ![]()
Molecular and Cellular Biology, December 2007, p. 8670-8682, Vol. 27, No. 24
0270-7306/07/$08.00+0 doi:10.1128/MCB.00635-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
,
Center for Cancer and Stem Cell Biology, Alkek Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, Texas 77030
Received 11 April 2007/ Returned for modification 26 June 2007/ Accepted 21 September 2007
|
|
|---|
|
|
|---|
Unlike nucleocytoplasmic translocation, proteins accumulate in the nucleolus via multiple mechanisms involving protein-protein, protein-RNA, and protein-DNA interactions. To date, no strong consensus sequence has been identified as the nucleolar localization signal (NoLS) for multiple proteins in a necessary and sufficient manner (3, 17, 31, 34, 41, 45), and very little is known about how proteins accumulate in the nucleolus and move between different subnuclear compartments at the molecular level. A common feature of most nucleolar localization regions is a stretch of positively charged residues that often overlap with the predicted nuclear localization signal. Yet, proteins with basic residue repeats do not always accumulate in the nucleolus. In addition, nucleolar localization can be modulated by signals beyond the primary protein sequence, such as GTP binding, H+ ion concentration, and phosphorylation (3, 18, 24, 38). In previous work, we used a stem cell-enriched factor, nucleostemin (NS), as a model molecule to address the mechanism controlling the dynamic distribution of nucleolar proteins. We have shown that the partitioning of NS between the nucleolus and the nucleoplasm involves multiple components and that GTP binding plays a key role in driving the dynamic cycling of NS (20, 21, 38, 39). The basic (B) domain of NS alone can accumulate in the nucleolus but is not sufficient to recapitulate its dynamic movement. Further modification of its nucleolar entry and retention is achieved by its GTP-binding (G) domain and the adjacent intermediate (I) domain. It is not entirely clear which of these mechanisms is shared by other proteins and which is unique for NS.
We reason that the conservation and divergence of nucleolar localization mechanisms may best be revealed by looking at multiple proteins that are structurally and evolutionarily related. The gene encoding NS is a member of a gene family that features an MMR_HSR1 domain. The MMR_HSR1 domain consists of five GTP-binding motifs arranged in a circularly permuted order, where a highly conserved G5 variant motif (hereafter referred to as a G5* motif) (DARXP) and the G4 (NKXDL) motif are positioned N terminally to the G1 (GXPNVGKSS), G2 (GXT), and G3 (DXPG) motifs (5, 16). Members of the MMR_HSR1 family are localized in different subcellular compartments of organisms from single-celled microorganisms to high vertebrates (32). Among them, NS, GNL3L (guanine nucleotide binding protein-like 3), and Ngp-1 (hereafter referred to as Ngp1) (28) form a subfamily of proteins found in the nucleolus. In this study, we dissect the shared and unique mechanisms controlling the nucleolar distribution of these three proteins. Based on our findings, we propose a model that depicts the nucleolar localization action as a combination of a positively charged region and a nucleoplasmic localization signal (NpLS), both of which can be further modulated in a protein-specific manner by a retention and an NpLS-regulating signal in the G domain.
|
|
|---|
Generation of deletion, point mutation, chimeric, and heterologous fusion constructs. Deletions, point mutations, and chimeric mutants were created by using the stitching PCR strategy as described previously (38, 39). The final products were subcloned into various expression vectors at the SalI and NotI sites for the N-terminal fusion or the SalI and AgeI sites for the C-terminal fusion. To generate C-terminally green fluorescent protein (GFP)-fused constructs, PCR fragments were subcloned into the pEGFP-N1 vector (Clontech). The N-terminal Myc epitope (EQKLISEED; EcoRI-SalI fragment) and the C-terminal hemagglutinin (HA) epitope (YPYDVPDYA; AgeI-NotI fragment) were engineered into the pCIS expression vector. All constructs were confirmed by sequencing reactions.
GTP-binding assay. GTP-binding assays were conducted as described previously (13, 38), using 1 µg of purified proteins and 80 µl of GTP-conjugated agarose (2.2 µmol/ml). After an extensive wash procedure, the amount of protein retained by the GTP-conjugated agarose was fractionated on a 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis gel and detected by Western blotting.
Cell culture, transfection, indirect immunofluorescence, and image acquisition. U2OS cells were used for all analyses in this study. Cells were maintained in Dulbecco's modified Eagle's medium supplemented with 5% fetal bovine serum (HyClone), penicillin (50 IU/ml), streptomycin (50 µg/ml), and glutamine (1%). Plasmid transfections were performed using Lipofectamine-plus reagent (Invitrogen) and analyzed 1 day after transfection. Immunofluorescence studies were performed as described previously (20, 38). The primary antibodies included monoclonal anti-HA antibody (1:2,000) (HA.11; Covance), monoclonal anti-Myc antibody (1:2,000) (9E10; Covance), monoclonal antifibrillarin antibody (1:1,000) (38F3; EnCor), and monoclonal anti-B23 antibody (1:4,000) (Zymed). All images were acquired by using a Zeiss LSM510 confocal microscope with a 63x plan-apochromat oil objective (numerical aperture, 1.4) and scanned with a 512 by 512 frame size, 3x zoom, and <1.4-µm optical thickness. The detector gain and amplifier offset were adjusted to ensure that all signals were appropriately displayed within the linear range of intensities.
FRAP and FLIP. U2OS cells were grown on Nalgene Lab Tek II chamber slides and transfected with 0.6 µg plasmid DNA 1 day before the measurement. Bleaching experiments were performed on a Zeiss LSM510 confocal microscope with a 63x plan-apochromat oil objective. The GFP signal was excited with a 488-nm argon laser (21 mW nominal output), and emissions above 505 nm were monitored. The cells were maintained at 35°C with a heat blower throughout the entire course of the fluorescence recovery after photobleaching (FRAP) and fluorescence loss in photobleaching (FLIP) experiments. To minimize the evaporation of the medium, the chambers were covered with lids bearing a small opening to allow contact between the thermosensor probe and the medium. The FRAP paradigm, modified based on previous reports (6, 27), was designed such that a circle of 1 µm in diameter was bleached inside the nucleolus by using a short laser pulse administered at 70% of the power of the 488-nm argon laser (21 mW nominal output) for three iterations which lasted for 256 ms. For image acquisition, the laser power was attenuated to 0.6% of the bleaching intensity, and cells were scanned with 5x zoom at 0.5-s intervals for 45 s after photobleaching. For quantification, the fluorescence intensities of the bleached area, the entire nucleus, and the area outside of the nucleus were measured. The relative fluorescence intensity (RFI) in the bleached area was normalized to the total intensity in the nucleus after background subtraction using the following calculation: RFI = (It/I0) x (TN0/TNt), where It and I0 are the background-subtracted intensities of the bleached spot at time point t and before photobleaching, respectively, and TNt and TN0 are the background-subtracted intensities of the entire nucleus at time point t and before photobleaching, respectively. Cells with a signal loss of >10% during the imaging phase were discarded. FLIP experiments were performed in which a 2- by 4-µm rectangular region in the nucleoplasm was bleached with repetitive pulses at 70% of the power of the 488-nm argon laser, with a 150-ms duration per pulse and a 0.59-s interval between consecutive pulses. For image acquisition, the laser power was attenuated to 0.6% of the bleach intensity, and the cells were scanned with 3x zoom at 0.74-s intervals. The RFI in the nucleolus of bleached cells was normalized to the nucleolar intensity of neighboring nonbleached cells after background subtraction using the following calculation: RFI = (It/I0) x (C0/Ct), where It and I0 are the background-subtracted intensities of the nucleolus in the bleached cell at time point t and before photobleaching, respectively, and Ct and C0 are the background-subtracted intensities of the nucleolus in the neighboring control cell at time point t and before photobleaching, respectively. Both the FRAP and the FLIP data represent the averages of the results for over 20 cells from two to four independent experiments.
|
|
|---|
![]() View larger version (51K): [in a new window] |
FIG. 1. NS, GNL3L, and Ngp1 represent a subfamily of GTP-binding proteins with distinct nucleolar localization properties. (A) A rooted phylogenetic tree of NS, GNL3L, and Ngp1 drawn with PHYLIP Drawgram version 3.2. The vertebrate NS genes (black lines) and the GNL3L genes (blue lines) share the same orthologues in the yeast (green lines), fruit fly, and pinworm (yellow lines), whereas the Ngp1 gene (red lines) is the same from yeast to humans. Species abbreviations: Bta, Bos taurus; Cel, Caenorhabditis elegans; Dme, Drosophila melanogaster; Dre, Danio rerio; Gga, Gallus gallus; Hsa, Homo sapiens; Mmu, Mus musculus; Rno, Rattus norvegicus; Sce, Saccharomyces cerevisiae; Spo, Schizosaccharomyces pombe; Xle, Xenopus laevis. (B) The protein sequences of the GTP-binding motifs of the NS family genes were aligned, and the positions of the highly conserved Asn residue (green) in the G4 motif and the Gly residue (red) in the G1 motif were numbered at the bottom. (C) Schematic diagrams of mouse NS, GNL3L, and Ngp1. All genes share an MMR_HSR1 structure, consisting of five circularly permuted GTP-binding motifs (G5*, G4, G1, G2, and G3) and some variations in the B, C, and A domains. Black square boxes indicate nuclear localization signals. (D) The subcellular distributions of NS, GNL3L, and Ngp1 in U2OS cells were revealed by a C-terminally fused GFP (green) and counterstained with anti-B23 immunofluorescence (red). Scale bar, 10 µm. (E) The FRAP recovery rates of NS, GNL3L, and Ngp1 were determined in the nucleoli of U2OS cells transfected with their respective GFP fusion constructs. (F) The FLIP rates of NS, GNL3L, and Ngp1 were measured in U2OS cells, where a small region in the nucleoplasm was repeatedly bleached and the loss of fluorescence signal in the nearest nucleolus was measured over time (see Materials and Methods and Fig. S1B in the supplemental material). The y axes represent the RFI (see Materials and Methods) in the bleached area (for FRAP) or in the nonbleached nucleolus (for FLIP). Error bars represent the standard deviations and are omitted on one side of the curves for clarity. Arrows indicate the bleaching events.
|
Nucleolar accumulation of GNL3L requires the B-C domain. To determine the protein structure required for the nucleolar localization of GNL3L, C-terminally GFP-fused GNL3L mutants were examined for their static and dynamic distributions (Fig. 2A). Our data showed that the N-terminal B and C1 domains of GNL3L of 80 amino acids are both necessary and sufficient for mediating nucleolar localization (Fig. 2B, mutants G3-dBC and G3-BC), consistent with the findings of a recent study (29). Deleting the B-C domain also reduces the nuclear translocation of GNL3L, and the cytoplasmic signal displays a significant colocalization with the cytoskeleton. By contrast, deleting the G domain (mutant G3-dG) or the I domain (mutant G3-dI) does not affect the nucleolar accumulation of GNL3L, and the G domain alone does not possess the nucleolar localization capability. To determine whether the distribution of GNL3L is regulated by its GTP-binding property, we first established its ability to bind GTP by using a biochemical assay in which GTP-conjugated agarose was incubated with purified GNL3L protein and washed extensively to remove unbound proteins (13, 38). Western blot analyses showed that GNL3L is retained by the GTP-conjugated agarose (Fig. 2C, WT). The pull-down of GNL3L can be specifically blocked by preincubating the purified GNL3L protein with 10 mM free GTP (Fig. 2C, WT+GTP) or by mutating the Asn166 residue to Ile (mutant G3-N166I). The Asn166 residue in the G4 motif and the Gly253 residue in the G1 motif of GNL3L correspond to the conserved Asn176 and Gly256 residues in NS (Fig. 1B, 2A) that have been shown to be essential for the GTP binding of NS (38). The N166I mutation also mimics the constitutive negative Ras mutant N116I (12). Mutating the Asn166 residue to Ile (mutant G3-N166I) or the Gly253 residue to Val (mutant G3-G253V) disrupts the nucleolar accumulation of GNL3L (Fig. 2D), supporting the idea that GTP binding regulates its nucleolar localization. While the FRAP recovery rate of the B-C domain (mutant G3-BC) resembles that of the full-length GNL3L, a deletion of the G domain (mutant G3-dG) or the I domain (mutant G3-dI) increases the nucleolar residence time of GNL3L (Fig. 2E). A subtle increase in the FRAP recovery rate of mutant G3-BC compared to the recovery rate of the wild-type GNL3L was seen. Whether it is caused by the different molecular weights of these two proteins or not is unclear. These results show that the B-C domain of GNL3L mimics its nucleolar distribution both statically and dynamically. Although the G domain of GNL3L is not sufficient to mediate nucleolar localization and lacks nucleolar retention activity like that of NS, GTP binding plays a regulatory role in the nucleolar accumulation of the full-length GNL3L.
![]() View larger version (41K): [in a new window] |
FIG. 2. The B-C domain of GNL3L is both necessary and sufficient to mediate nucleolar localization. For nucleolar accumulation of the full-length GNL3L, GTP binding is required. (A) Truncated mutants with C-terminally fused GFP were designed to determine the structural requirement for the nucleolar localization of GNL3L. Numbers and black boxes indicate amino acid positions and nuclear localization signals, respectively. Yellow boxes represent, from left to right, the G5*, G1, and G4 motifs. (B) The B-C1 domain is both necessary and sufficient for mediating nucleolar localization. Anti-B23 immunofluorescence of the same cell at a 60% scale is shown in the upper right quadrant of each cell. (C) Wild-type GNL3L (WT) can be retained by GTP-conjugated agarose. The GTP binding of GNL3L is blocked by preincubating GNL3L with 10 mM free GTP (WT+GTP) or by mutating the Asn166 residue in the G4 domain to Ile (mutant G3-N166I). B, bound fraction; S, supernatant. (D) Mutating the Asn166 residue to Ile (mutant G3-N166I) or the Gly253 residue to Val (mutant G3-G253V) perturbs the nucleolar distribution of GNL3L. Anti-B23 staining is shown in the upper right quadrant of each panel. (E) The nucleolar FRAP curves depict the averages of the RFI results in the bleached area relative to the prebleach intensity (set at 1; n = 20) over a 45-s period following photobleaching. Error bars showing standard deviations are omitted on one side for clarity. The FRAP recovery rate of the wild-type protein (GNL3L) mostly resembles the recovery rate of the B-C domain (mutant G3-BC). The arrow indicates the bleach pulse. Scale bars in panels B and D show 10 µm.
|
![]() View larger version (41K): [in a new window] |
FIG. 3. The B domains of Ngp1 mediate its nucleolar accumulation, and the G domain controls its nucleolar retention time. (A) C-terminally GFP-fused mutants of Ngp1 were constructed to map the protein domains involved in its static and dynamic distributions. Numbers and black boxes indicate amino acid positions and nuclear localization signals, respectively. Bent line segments indicate deleted protein regions. (B) Distribution analyses showed that deleting both the B1 and B2 domains (mutant G2-dB) disrupts the nucleolar accumulation of Ngp1. The B1-B2 deletion plus a mutation on the Asn255 residue in the G4 motif (mutant G2-dBN255I) or on the Gly317 residue in the G1 motif (mutant G2-dBG317V) completely exclude the protein from the nucleolus. The B1 plus B2 domain (mutant G2-B1B2), but not the G domain (mutant G2-G), is sufficient for accumulation in the nucleolus. Anti-B23 immunofluorescence of the same cells at a 60% scale is shown in the upper right quadrant of each panel. (C) Ngp1 can be retained by GTP-conjugated agarose. The GTP binding of Ngp1 is abolished by preincubating Ngp1 with 10 mM free GTP (WT+GTP) or by mutating the Asn255 residue to Ile (mutant G2-N255I). B, bound fraction; S, supernatant. (D) A single-residue mutation on Asn255 or Gly317 partially perturbs the nucleolar accumulation of Ngp1. (E) Nucleolar FRAP experiments showed that while the B1-B2 domain is necessary and sufficient for mediating nucleolar distribution, it is not enough to recapitulate the dynamic property of the full-length Ngp1 (mutant G2-B1B2). It is the non-nucleolus-targeting G domain that contributes to the retention property of Ngp1 (mutant G2-dG). Deleting the I or AC domain does not alter the dynamic property of Ngp1. Scale bars in panels B and D show 10 µm.
|
![]() View larger version (125K): [in a new window] |
FIG. 4. Nucleolar accumulation of GNL3L and Ngp1 are controlled by a G-domain-regulated NpLS in the I or IAC domain. (A and B) The nucleolar localization of the G3-N166I (A1) and G2-N255I (B1) mutants can be restored by a deletion of the I domain of GNL3L (A2) or the I or IAC domain of Ngp1 (B2 and B4), but not by a deletion of the AC domain of Ngp1 (B3). The distributions of the mutant proteins were detected by using a C-terminally fused GFP (top panels) and counterstained with anti-B23 immunofluorescence (bottom panels). (C to H) The NpLS activity of the I and IAC domains of GNL3L and Ngp1 remains functional when they are fused to another nucleolar protein, B23. The distribution patterns of B23 (C and F) and B23 fusion proteins (D, E, G, and H) were detected by using a C-terminal HA tag (C to E, upper panels) or an N-terminal Myc tag (F to H, upper panels) and double labeled with antifibrillarin immunofluorescence (Fib, lower panels). The I domain of GNL3L (D1 and G1) and the IAC domain of Ngp1 (E2 and H2), but not the I domain of Ngp1 (E1 and H1), can reduce the nucleolar accumulation of B23. The NpLS activities of the I domain of GNL3L and the IAC domain of Ngp1 can be neutralized by their respective wild-type G domains (D2, E3, G2, and H3), but not by the mutant G domain (G*) with the N166I mutation (for GNL3L; D3 and G3) or the N255I mutation (for Ngp1; E4 and H4). Dashed lines demarcate the nucleocytoplasmic boundaries. The designs of the fusion constructs are depicted below the panels. Black boxes indicate the HA or Myc epitope. Scale bars, 10 µm.
|
|
View larger version (12K): [in a new window] |
FIG. 5. The NpLS activity of the I domain of NS and, to a lesser extent, GNL3L, is mediated by a nucleoplasmic retention mechanism. The exchange rates between the nucleolus and the nucleoplasm of the B23 and B23-NpLS domain fusion proteins were measured by the nucleolar FRAP paradigm described in the legend to Fig. 1E. (A) The FRAP recovery rate of the NS I domain fused to the B23 protein [B23-I(NS)] is significantly delayed compared to the recovery rate of the control B23 protein. (B) The FRAP recovery rate of the GNL3L I domain fused to the B23 protein shows a slight but statistically significant decrease at the 5-, 10-, and 15-s time points compared to the recovery rate of the control B23 protein (P < 0.005; n = 50). (C) The FRAP recovery rates of the Ngp1 IAC domain fused to the B23 protein and the control B23 protein are identical. Error bars showing standard deviations are omitted on one side of the curves for clarity.
|
![]() View larger version (38K): [in a new window] |
FIG. 6. The B-C domains can be exchanged between NS and GNL3L and still maintain their relative activities, but the ability of the G domain to regulate the NpLS activity is protein specific. Chimeric proteins of NS and GNL3L were created that cross over at the highly conserved G5* and G1 motifs (see Fig. S4 in the supplemental material for details). Protein distribution was detected by using a C-terminally fused GFP and counterstained with antifibrillarin (Fib) antibody. When only the B-C domains are switched, the chimeric proteins NS211 (A1) and NS122 (A2) maintain their nucleolar distribution, and their FRAP recovery rates fall between those of NS and GNL3L (A3). When the G domain of NS is fused to the NpLS domain of GNL3L, the chimeric protein appears nucleolar (B1; NS112) or diffuse (B2; NS212), depending on which B-C domain it is coupled to. The FRAP recovery rates of these two mutants are as slow as or slower than that of NS (B3). When the G domain of GNL3L is fused to the NpLS domain of NS, the chimeric proteins are diffusely localized in the nucleus (C1 and C2), and their protein exchange rates are as fast as that of GNL3L (C3). The chimeric protein structures are depicted below the panels, with light and dark grey boxes representing protein origin from NS or GNL3L, respectively.
|
The fact that the G-domain activity cannot be predicted based on the overall protein homology suggests that a few amino acids may play a decisive role. To resolve the protein-specific activity of the G domain at the single-residue level, we targeted specific amino acids that are located between the G5* and G1 motifs and are highly conserved among the NS and Ngp1 genes of different species but are not shared by GNL3L. Using these three criteria, we identified a Lys residue in NS (Lys232) and Ngp1 (Lys291) that is highly conserved throughout evolution and corresponds to an Ala residue in GNL3L (A227). Another amino acid, Pro157 in NS or Pro235 in Ngp1, fulfills the same criteria, except for the frog and zebra fish GNL3L proteins (Fig. 7A). Each member of the NS family proteins also possesses a unique amino acid in the G4 motif (Ser178 in NS, Ile168 in GNL3L, and Cys257 in Ngp1) and in the G1 motif (Phe257 in NS, Leu254 in GNL3L, and Tyr318 in Ngp1) (Fig. 7A). In the first set of experiments, we replaced a single amino acid in NS at one of these four sites with the corresponding amino acid found in GNL3L (P157F, S178I, K232A, and F257L), as well as creating mutants with combined mutations of P157F and S178I (P157F-S178I; mutant D1) or K232A-F257L (mutant D2) (Fig. 7B). Statically, all six mutants are localized predominantly in the nucleolus (Fig. 7C). Dynamically, the K232A and S178I mutants exhibit a faster FRAP recovery rate than the wild-type NS, whereas the P157F and F257L mutants differ from the wild-type NS primarily in their recovery plateau level (Fig. 7D and Table 1). The FRAP recovery rates of the D1 and D2 mutants fall between those of the mutants with their respective single residues, indicating that the effects of these single-residue mutations on the dynamic property of NS are additive (Fig. 7E). The fast protein exchange rates of the K232A and S178I mutants were confirmed by FLIP experiments in which fluorescence loss in the nucleolus was recorded while a 2- by 4-µm area in the nucleoplasm was repeatedly bleached (Fig. 7F). Notably, the FLIP rate of the P157F mutant is faster than that of wild-type NS, and the loss of F257L signal in the nucleolus is faster than the loss of wild-type signal during the first 30 s of photobleaching.
![]() View larger version (38K): [in a new window] |
FIG. 7. A combined A227K-L254F mutation on GNL3L mimics the effect of swapping its G domain with that of NS. (A) To identify the amino acids located between the G5* and G1 motifs that play a key role in mediating the nucleolar retention and the NpLS-regulating activities of the G domain, the protein sequences of the G5*-to-G1 domain of the vertebrate NS family proteins were aligned by using the ClustalW program. The four residues that are either shared by NS and Ngp1 but not by GNL3L or uniquely conserved in each member of the NS family (numbered and highlighted) were chosen for the amino acid substitution experiments. (B) Single-amino-acid substitutions were made on NS at one or two of these four sites. (C) Static distributions of NS mutant proteins were detected by using C-terminally fused GFP and counterstained with anti-B23 immunofluorescence, shown on a 60% scale in the upper right quadrant of each panel. (D) FRAP analyses showed that single-residue mutants K232A and S178I display a faster recovery rate than the wild-type NS. The P157F and F257L mutants reach a lower plateau level than the wild-type NS. (E) The FRAP recovery rates of double-residue mutants D1 and D2 fall between those of their respective single-residue mutants. (F) FLIP experiments showed that the nucleolar retention times of the P157L, S178I, and K232A mutants are decreased compared to that of the wild-type NS. The FLIP rate of the F257L mutant is faster than that of the wild-type NS during the first 30 s of photobleaching. (G) Single-amino-acid substitutions were made on GNL3L at one or two of the four targeted sites. (H) The distributions of mutant GNL3L proteins were shown by a C-terminally fused GFP and counterstained with anti-B23 immunofluorescence, shown on a 60% scale in the upper right quadrant of each panel. Unlike the wild-type GNL3L, the double-residue GNL3L mutant K2 (A227K-L254F) is distributed diffusely in the nucleus. (I and J) FRAP analyses showed that the single-residue GNL3L mutant A227K (I) has a mild increase and the double-residue mutant K2 (J) has a significant increase in the nucleolar retention time. (K) FLIP experiments confirm the FRAP findings for A227K and K2 mutants. Scale bars in panels C and H show 10 µm.
|
|
View this table: [in a new window] |
TABLE 1. Statistical analyses of FRAP recovery rates of single- and double-residue mutations on NS and GNL3L
|
|
|
|---|
Analyses of the NS-GNL3L chimeric proteins with mismatched G and NpLS domains reveal that the nucleolar retention signal of NS can slow down the protein exchange rate regardless of whether the protein accumulates in the nucleolus or in the nucleoplasm (Fig. 6B, mutants NS112 and NS212). Furthermore, the ability of the G domain to neutralize the activity of NpLS is distinct among the NS family proteins. Even though they share 53% protein sequence identity, the same domain structure, and the same yeast orthologue, neither the G domain of NS nor that of GNL3L can fully cross-regulate the NpLS activity of the other protein. Amino acid substitution experiments showed that a Lys-to-Ala switch can reciprocally affect the nucleolar retention times of NS and GNL3L. The combined mutation A227K-L254F on GNL3L disrupts its nucleolar accumulation and significantly increases its retention time in much the same way as swapping the G5*-to-G1 domain of GNL3L with that of NS (mutant NS212). Although the F146P and L254F mutations have no apparent effect on the dynamic distribution of GNL3L, the reverse mutations on NS (P157F and F257L) lead to a lower FRAP recovery plateau in a way that is similar to the recovery plateau of Ngp1. This finding suggests that such mutations render a portion of NS in the nucleolus unexchangeable within the time frame of our recording. Notably, the FLIP rate of P157F is faster than that of the wild-type NS, which resembles the dynamic property of Ngp1 as well. In this study, we specifically targeted the residues that are shared by NS and Ngp1, but not by GNL3L, based on the rationale that NS and Ngp1 reside in the nucleolus longer than GNL3L does. We also investigated the function of two residues in the G4 and G1 domains that are distinct among NS, GNL3L, and Ngp1 but highly conserved throughout evolution. Although our data do not exclude the possibility that other, nonconserved amino acids or the peptidyl length may contribute to the G-domain activity, they demonstrate that the protein-specific retention and NpLS-regulating activities of the G domain are mediated largely by a few key residues that are difficult to predict based on the overall protein homology.
Based on our data, one can envision several molecular models to explain the accumulation and dynamic exchange of nuclear proteins between the nucleolar and nucleoplasmic compartments. A common mechanism shared by most, if not all, nucleolar proteins involves a stretch of positively charged residues that permits them to accumulate in the nucleolus (Fig. 8A). This region can be transferred to another protein and still maintain its nucleolar localization activity. In addition to this most commonly identified nucleolar localization sequence, a retention signal and an NpLS exist in some or all of the NS family proteins which modulate their static and dynamic distributions. The retention signal can increase the retention time of proteins localized in the nucleolus (Fig. 8B) or in the nucleoplasm (Fig. 8C). The NpLS possesses the ability to redistribute nucleolar proteins from the nucleolus to the nucleoplasm. This NpLS activity can be constitutively active, in which case the protein appears nucleoplasmic (Fig. 8D), or it can be turned on and off to allow for a regulated distribution between the nucleolus and the nucleoplasm (Fig. 8E). Finally, the nucleolar retention and the NpLS-regulating activities of the G domain involve specific residues that cannot be predicted based on the overall protein homology.
|
View larger version (6K): [in a new window] |
FIG. 8. The mechanism underlying nucleolar localization may include a nucleolus-targeting B domain, a retention signal, and an NpLS coupled with a regulatory module. In addition to the commonly identified, positively charged (+) B domain, the static and dynamic distribution of nucleolar proteins between the nucleolus (rounded rectangles) and the nucleoplasm can be further modified by a retention signal, an NpLS, or a combination of both. By itself, the B domain can accumulate in the nucleolus with a short nucleolar retention time, represented by thick arrows (A). The addition of a retention signal (RS) can slow down the protein exchange rate, indicated by thin arrows, of both nucleolar (B) and nucleoplasmic proteins (C). The ability of the NpLS to detain proteins with nucleolar localization capability in the nucleoplasm can be constitutively active (D) or regulated by a regulatory module (E). For NS and Ngp1, the G domain functions as both the retention signal and the regulatory module for the NpLS.
|
does not require its nucleolus-localizing B-C domain and can be increased only slightly by the NS122 mutation that increases its nucleolar retention (44). One inference of this finding is that it is less likely that the mechanism of nucleolar sequestration is used by proteins with a short nucleolar residence time, like GNL3L, than by proteins with a long nucleolar residence time, like NS or Ngp1. In conclusion, our data reveal two novel activities associated with the G domain that function as a retention signal and an NpLS regulator, as well as an NpLS activity in the I (or IAC) domain. We propose that nucleolar localization is determined by a balance between the positively charged domain, a protein-specific retention signal, and an NpLS, which operate in concert to achieve a controlled distribution of proteins inside the nucleus. This knowledge of dynamic protein trafficking to and from the nucleolus will cast new light on the regulation of fast biological events taking place in the nucleus.
This work was supported by Public Health Service grant CA113750 awarded to R. Y. L. Tsai.
Published ahead of print on 8 October 2007. ![]()
Supplemental material for this article may be found at http://mcb.asm.org/. ![]()
|
|
|---|
by competing for coactivator binding. J. Cell Sci. 120:2532-2543.This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»